Brainsway (NASDAQ: BWAY) director details stock options and 6,250 RSUs

Rhea-AI Filing Summary

Brainsway Ltd. director Lushi Avner reported initial equity holdings consisting of stock options and restricted stock units tied to the company’s ordinary shares. The filing shows stock options to purchase 12,500 ordinary shares, granted on March 5, 2024, with the remaining options vesting in equal quarterly installments until March 5, 2028 and expiring on March 5, 2034. The exercise price for these options is NIS 11.17 per share. In addition, Avner holds 6,250 unvested RSUs, each representing a contingent right to receive one ordinary share, vesting quarterly until March 5, 2028. The ordinary shares may be represented by American Depositary Shares, with each ADS currently corresponding to one ordinary share.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lushi Avner

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	6,250	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	03/05/2034	Ordinary Shares(1)	12,500	(4)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure represents unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

3. Stock options were granted on March 5, 2024, with the remaining options to purchase 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.

4. The exercise price is NIS 11.17 per share.

	/s/ Avner Lushi	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider holdings did Lushi Avner report in Brainsway (BWAY) Form 3?

Lushi Avner reported stock options over 12,500 Brainsway ordinary shares and 6,250 unvested RSUs. The options and RSUs provide future rights to receive shares as they vest over time, subject to their schedules.

How do Lushi Avner’s Brainsway (BWAY) stock options vest and when do they expire?

The stock options were granted March 5, 2024, with remaining options on 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028. These options expire on March 5, 2034, if not exercised before that date.

What is the exercise price of Lushi Avner’s Brainsway (BWAY) stock options?

The exercise price for Lushi Avner’s Brainsway stock options is NIS 11.17 per ordinary share. This is the price Avner must pay per share to exercise the options, regardless of the market price at the time of exercise.

What are the terms of Lushi Avner’s 6,250 RSUs in Brainsway (BWAY)?

The 6,250 RSUs are unvested restricted stock units that vest quarterly until March 5, 2028. Each RSU represents a contingent right to receive one Brainsway ordinary share as vesting milestones are met over time.

How are Brainsway (BWAY) ordinary shares related to its American Depositary Shares (ADSs)?

Brainsway’s ordinary shares may be represented by American Depositary Shares, with each ADS currently representing one ordinary share. This 1:1 relationship allows U.S. investors to hold ADSs that correspond directly to underlying ordinary shares.